Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Kramer

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Bone Research|August 23, 2023
Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5Cassandra R Diegel, Ina Kramer, Charles Moes, et al.
Journal of Cellular Physiology|May 2, 2017
The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesisHeather Fairfield, Carolyne Falank, Elizabeth Harris, et al.
Kidney International|August 17, 2016
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney diseaseDaniel Cejka, Diego Parada-Rodriguez, Stefanie Pichler, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2016
Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct MechanismsAbhishek Chandra, Tiao Lin, Tiffany Young, et al.
Scientific Reports|August 27, 2017
Sost deficiency led to a greater cortical bone formation response to mechanical loading and altered gene expressionDavid Pflanz, Annette I Birkhold, Laia Albiol, et al.
Human Molecular Genetics|June 5, 2016
Meckel's and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandibleMartin Biosse Duplan, Davide Komla-Ebri, Yann Heuzé, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2018
Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental SpondyloarthritisMelissa N van Tok, Leonie M van Duivenvoorde, Ina Kramer, et al.
Bone|November 28, 2017
Sclerostin deficiency modifies the development of CKD-MBD in miceNadine Kaesler, Anja Verhulst, Annelies De Maré, et al.
The Journal of Clinical Investigation|April 12, 2016
Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse modelDavide Komla-Ebri, Emilie Dambroise, Ina Kramer, et al.
Science Translational Medicine|April 19, 2016
Sclerostin inhibition promotes TNF-dependent inflammatory joint destructionCorinna Wehmeyer, Svetlana Frank, Denise Beckmann, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Bone Research|August 23, 2023
Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5Cassandra R Diegel, Ina Kramer, Charles Moes, et al.
Journal of Cellular Physiology|May 2, 2017
The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesisHeather Fairfield, Carolyne Falank, Elizabeth Harris, et al.
Kidney International|August 17, 2016
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney diseaseDaniel Cejka, Diego Parada-Rodriguez, Stefanie Pichler, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2016
Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct MechanismsAbhishek Chandra, Tiao Lin, Tiffany Young, et al.
Scientific Reports|August 27, 2017
Sost deficiency led to a greater cortical bone formation response to mechanical loading and altered gene expressionDavid Pflanz, Annette I Birkhold, Laia Albiol, et al.
Human Molecular Genetics|June 5, 2016
Meckel's and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandibleMartin Biosse Duplan, Davide Komla-Ebri, Yann Heuzé, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2018
Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental SpondyloarthritisMelissa N van Tok, Leonie M van Duivenvoorde, Ina Kramer, et al.
Bone|November 28, 2017
Sclerostin deficiency modifies the development of CKD-MBD in miceNadine Kaesler, Anja Verhulst, Annelies De Maré, et al.
The Journal of Clinical Investigation|April 12, 2016
Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse modelDavide Komla-Ebri, Emilie Dambroise, Ina Kramer, et al.
Science Translational Medicine|April 19, 2016
Sclerostin inhibition promotes TNF-dependent inflammatory joint destructionCorinna Wehmeyer, Svetlana Frank, Denise Beckmann, et al.
Pageof 5